Innovation Pharmaceuticals’ Brilacidin Inhibits Novel Coronavirus (COVID-19) by Almost 90% at the Lowest Concentration Tested to Date in a Human Lung Cell Line

… SARS-CoV-2, the novel coronavirus responsible for COVID- … .U., U.K., India, Singapore, Japan, and Australia. In the … rapidly help address the novel coronavirus crisis. Ongoing laboratory … Brilacidin as a promising novel coronavirus treatment. Additional pre …